Axis Securities has initiated coverage on Indegene with a 'BUY' rating and a target price of Rs 705, representing a potential 18% upside from the current market price. The brokerage cites the company's strong position in the life sciences digital services market, its proprietary 'Cortex' AI platform, and a robust revenue growth forecast as key drivers. Investors should note that the firm expects a 25% revenue CAGR through FY29, supported by deep domain expertise and client expansion strategies.
Axis Securities Initiates Coverage on Indegene with BUY
Target Price: Rs 705 | Expected Upside: 18%
Reader Takeaway: Indegene benefits from AI-driven efficiency in pharma workflows, but faces risks from client tech internalisation and FX volatility.
What just happened
Axis Securities has officially initiated coverage on Indegene, assigning a 'BUY' rating with a target price of Rs 705 per share. Based on a Discounted Cash Flow (DCF) valuation, the brokerage anticipates an 18% upside from the current market price of Rs 598. The outlook is supported by a projected 25% revenue CAGR over the FY26-FY29 period.
Why this matters
The brokerage highlights three primary catalysts: deep domain expertise in regulated biopharma workflows, a proven 'land-and-expand' client strategy, and the scalability of its proprietary 'Cortex' GenAI engine. Indegene currently reports the highest revenue per employee among its domestic IT peers, signaling high operational efficiency.
Financial Outlook
Axis Securities projects significant bottom-line growth over the next three fiscal years. Net profit is estimated to grow from Rs 401 crore in FY26 to Rs 807 crore by FY29E. EBIT margins are expected to benefit from operating leverage and the normalization of recent investment costs.
Risks to watch
- Client Internalisation: Clients developing their own AI solutions could reduce reliance on external providers.
- Integration Hurdles: Challenges in assimilating new acquisitions and managing potential cultural mismatches.
- Currency Sensitivity: As a significant portion of revenue is generated in USD, INR-USD fluctuations directly affect reported earnings.
- Talent Retention: Dependence on specialized domain experts makes attrition a critical operational risk.
What to track next
Investors should monitor the scaling of the 'Cortex' platform and the company's ability to maintain double-digit EBIT margins within its Enterprise Communication Solutions (ECS) segment as it continues its acquisition-led growth trajectory.